Graphene Oxide Quantum Dots-Preactivated Dental Pulp Stem Cells/GelMA Facilitates Mitophagy-Regulated Bone Regeneration
Xiaoyuan Yan,Na An,Zeying Zhang,Qiujing Qiu,Di Yang,Penggong Wei,Xiyue Zhang,Lihong Qiu,Jiajie Guo
DOI: https://doi.org/10.2147/ijn.s480979
IF: 7.033
2024-10-04
International Journal of Nanomedicine
Abstract:Xiaoyuan Yan, 1 Na An, 2 Zeying Zhang, 1 Qiujing Qiu, 1 Di Yang, 1 Penggong Wei, 1 Xiyue Zhang, 1 Lihong Qiu, 1 Jiajie Guo 1 1 Department of Endodontics, School and Hospital of Stomatology, China Medical University, Liaoning Provincial Key Laboratory of Oral Diseases, Shenyang, People's Republic of China; 2 Department of Orthodontics, School and Hospital of Stomatology, China Medical University, Liaoning Provincial Key Laboratory of Oral Diseases, Shenyang, People's Republic of China Correspondence: Lihong Qiu; Jiajie Guo, Department of Endodontics, School and Hospital of Stomatology, China Medical University, Liaoning Provincial Key Laboratory of Oral Diseases, No. 117 Nanjing North Street, Heping District, Shenyang, Liaoning Province, People's Republic of China, Email ; Background: In bone tissue engineering (BTE), cell-laden scaffolds offer a promising strategy for repairing bone defects, particularly when host cell regeneration is insufficient due to age or disease. Exogenous stem cell-based BTE requires bioactive factors to activate these cells. Graphene oxide quantum dots (GOQDs), zero-dimensional derivatives of graphene oxide, have emerged as potential osteogenic nanomedicines. However, constructing biological scaffolds with GOQDs and elucidating their biological mechanisms remain critical challenges. Methods: We utilized GOQDs with a particle size of 10 nm, characterized by a surface rich in C–O–H and C–O–C functional groups. We developed a gelatin methacryloyl (GelMA) hydrogel incorporated with GOQDs-treated dental pulp stem cells (DPSCs). These constructs were transplanted into rat calvarial bone defects to estimate the effectiveness of GOQDs-induced DPSCs in repairing bone defects while also investigating the molecular mechanism underlying GOQDs-induced osteogenesis in DPSCs. Results: GOQDs at 5 μg/mL significantly enhanced the osteogenic differentiation of DPSCs without toxicity. The GOQDs-induced DPSCs showed active osteogenic potential in three-dimensional cell culture system. In vivo, transplantation of GOQDs-preactivated DPSCs/GelMA composite effectively facilitated calvarial bone regeneration. Mechanistically, GOQDs stimulated mitophagy flux through the phosphatase-and-tensin homolog-induced putative kinase 1 (PINK1)/Parkin E3 ubiquitin ligase (PRKN) pathway. Notably, inhibiting mitophagy with cyclosporin A prevented the osteogenic activity of GOQDs. Conclusion: This research presents a well-designed bionic GOQDs/DPSCs/GelMA composite scaffold and demonstrated its ability to promote bone regeneration by enhancing mitophagy. These findings highlight the significant potential of this composite for application in BTE and underscore the crucial role of mitophagy in promoting the osteogenic differentiation of GOQDs-induced stem cells. Keywords: graphene oxide quantum dots, dental pulp stem cells, osteogenesis, bone regeneration, mitophagy Bone tissue engineering (BTE) has emerged as a promising approach for treating bone defects, utilizing biomimetic substitutes composed of seed cells, bioactive factors and scaffolds. 1 Compared with acellular scaffolds, cell-laden scaffolds demonstrate greater therapeutic potential for repairing bone defects, particularly in patients with insufficient host cell regeneration due to age, disease, or other factors. Dental pulp stem cells (DPSCs) are mesenchymal stem cells (MSCs) found in dental pulp tissue, characterized by their multidirectional differentiation potential. They can differentiate into odontoblasts, osteoblasts, chondroblasts, adipocytes, and neuronal cells in vitro after drug induction. 2,3 A significant number of intact wisdom teeth and teeth extracted for orthodontic reduction can serve as sources of DPSCs. This abundance of DPSCs provides an advantage over bone marrow stem cells (BMSCs), which are the traditional seed cells used in BTE, as their acquisition does not entail additional trauma or pain for patients. Since the differentiation efficiency of exogenous stem cells at the recipient site may be limited by the host microenvironment, bioactive factors that promote differentiation become increasingly important. However, the most commonly used bioactive factors in BTE, bone morphogenetic proteins (BMPs), are expensive and can lead to clinical side effects, including ectopic bone and arthritis. 4–6 Consequently, new bone regeneration medicines that are safe and effective are still needed. Graphene oxide quantum dots (GOQDs) are a type of zero-dimensional carbon nanomaterial with a lateral size less than 20 nm. 7 Although GOQDs are derivatives of graphene oxide (GO), they are smaller, more biocompatible, and can -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology